We are live on
!
Find out more
SC
SMA Capital Portfolio holdings
AUM
$238M
This Fund
S&P 500
This Quarter
Est. Return
+14.62%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$238M
AUM Growth
+$6.45M
(+2.8%)
Cap. Flow
-$11.8M
Cap. Flow
% of AUM
-4.96%
Top 10 Holdings %
Top 10 Hldgs %
37.07%
Holding
184
New
89
Increased
22
Reduced
10
Closed
63
Avg Time Held
0.3
quarters
Top 10 Avg Time Held
0.9
quarters
Top 20 Avg Time Held
0.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$7.92M |
| 2 |
ITT
ITT
|
+$7.28M |
| 3 |
Packaging Corp of America
PKG
|
+$7.02M |
| 4 |
JB Hunt Transport Services
JBHT
|
+$6.42M |
| 5 |
Teledyne Technologies
TDY
|
+$6.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$10.3M |
| 2 |
Eaton
ETN
|
+$10.1M |
| 3 |
Caterpillar
CAT
|
+$9.48M |
| 4 |
Ferguson
FERG
|
+$8.32M |
| 5 |
Linde
LIN
|
+$7.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 55.56% |
| 2 | Consumer Discretionary | 17.53% |
| 3 | Technology | 8.66% |
| 4 | Materials | 6.15% |
| 5 | Consumer Staples | 4.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Penumbra
PEN
$12.6B
| $30.9K | 0.01% |
98
+33
| +51% | +$10.7K |
2026 Q1
1 quarter
|
|
77
Intuitive Surgical
ISRG
$150B
| $30.6K | 0.01% |
77
+32
| +71% | +$14K |
2026 Q1
1 quarter
|
|
78
Axogen
AXGN
$2.12B
| $28K | 0.01% |
+606
| New | +$24.4K |
2026 Q2
0 quarters
|
|
79
Alignment Healthcare
ALHC
$1.56B
| $27.7K | 0.01% |
1,165
+13
| +1% | +$250 |
2026 Q1
1 quarter
|
|
80
Option Care Health
OPCH
$4.65B
| $27.7K | 0.01% |
1,320
+612
| +86% | +$14.2K |
2026 Q1
1 quarter
|
|
81
Progyny
PGNY
$2.14B
| $27.6K | 0.01% |
+959
| New | +$21.4K |
2026 Q2
0 quarters
|
|
82
Privia Health
PRVA
$2.66B
| $27.6K | 0.01% |
+1,074
| New | +$24.9K |
2026 Q2
0 quarters
|
|
83
Glaukos
GKOS
$9.77B
| $27.5K | 0.01% |
+197
| New | +$24.9K |
2026 Q2
0 quarters
|
|
84
Lifestance Health
LFST
$4.72B
| $27.5K | 0.01% |
+2,570
| New | +$19.9K |
2026 Q2
0 quarters
|
|
85
Chemed
CHE
$6.53B
| $27.5K | 0.01% |
59
+6
| +11% | +$2.52K |
2026 Q1
1 quarter
|
|
86
Clover Health Investments
CLOV
$2.54B
| $27.4K | 0.01% |
+5,221
| New | +$17.7K |
2026 Q2
0 quarters
|
|
87
BridgeBio Pharma
BBIO
$12.8B
| $21K | 0.01% |
282
-71
| -20% | -$4.97K |
2026 Q1
1 quarter
|
|
88
Revolution Medicines
RVMD
$40.7B
| $21K | 0.01% |
+112
| New | +$16.4K |
2026 Q2
0 quarters
|
|
89
Gilead Sciences
GILD
$187B
| $20.8K | 0.01% |
+165
| New | +$21.7K |
2026 Q2
0 quarters
|
|
90
Roivant Sciences
ROIV
$25.6B
| $20.8K | 0.01% |
+589
| New | +$17.4K |
2026 Q2
0 quarters
|
|
91
Moderna
MRNA
$89.8B
| $20.8K | 0.01% |
297
-124
| -29% | -$6.42K |
2026 Q1
1 quarter
|
|
92
Cytokinetics
CYTK
$8.75B
| $20.8K | 0.01% |
244
+145
| +146% | +$10.4K |
2026 Q1
1 quarter
|
|
93
Ionis Pharmaceuticals
IONS
$7.52B
| $20.6K | 0.01% |
+260
| New | +$19.6K |
2026 Q2
0 quarters
|
|
94
Axsome Therapeutics
AXSM
$8.82B
| $20.6K | 0.01% |
84
+48
| +133% | +$10.4K |
2026 Q1
1 quarter
|
|
95
Neurocrine Biosciences
NBIX
$14.5B
| $20.6K | 0.01% |
+122
| New | +$18.1K |
2026 Q2
0 quarters
|
|
96
Krystal Biotech
KRYS
$9.82B
| $20.4K | 0.01% |
+55
| New | +$16.4K |
2026 Q2
0 quarters
|
|
97
Madrigal Pharmaceuticals
MDGL
$10.9B
| $20.4K | 0.01% |
+38
| New | +$19.5K |
2026 Q2
0 quarters
|
|
98
Sotera Health
SHC
$5.15B
| $11.3K | ﹤0.01% |
639
+256
| +67% | +$4.04K |
2026 Q1
1 quarter
|
|
99
Indivior Pharmaceuticals
INDV
$4.23B
| $11.3K | ﹤0.01% |
+276
| New | +$10K |
2026 Q2
0 quarters
|
|
|
NUVL
100
DELISTED
Nuvalent
NUVL
| $11.1K | ﹤0.01% |
+90
| New | +$9.68K |
2026 Q2
0 quarters
|
|
Similar funds
RMC
PFA
TCM
SAM
CWM
CNBOF
NSB
CCA
SMA Capital's Q2 2026 Portfolio in Review
As of Q2 2026, SMA Capital held 184 positions worth $238M, up 2.8% from $232M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
SMA Capital withdrew a net $11.8M in Q2 2026, closing 63 positions and reducing 10 holdings. Its most notable exit was Boeing, an estimated $10.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 56% of assets, down from 79% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, SMA Capital opened a new position in CRH worth $7.7M.
- SMA Capital's largest Q2 2026 buy was CRH: 72,000 shares worth $7.7M.
- SMA Capital added most to Ametek in Q2 2026, an estimated $2.33M increase.
- SMA Capital's biggest Q2 2026 reduction was Applied Industrial Technologies, cutting an estimated $5.83M.
- SMA Capital fully exited Boeing in Q2 2026, selling an estimated $10.3M.
- SMA Capital's ten largest holdings make up 37% of its $238M portfolio in Q2 2026.
- SMA Capital opened 89 new positions and closed 63 in Q2 2026.
- SMA Capital's portfolio value rose 2.8% quarter-over-quarter to $238M.
Based on SMA Capital's 13F filing for Q2 2026, filed 14 Aug 2026.